ASCO Education

191 Episoade

1. Recently Approved Drugs: Durvalumab for patients with stage III Non-Small Cell Lung Cancers (NSCLC)

   Publicat: 27.06.2018
2. Self-Evaluation: Special histologies - lymphoma: Primary CNS, appropriate first line therapy for newly diagnosed primary CNS lymphoma

   Publicat: 20.06.2018
3. ASCO Guideline: Fertility Preservation in Patients with Cancer

   Publicat: 13.06.2018
4. Self-Evaluation: EGFR Mutation

   Publicat: 06.06.2018
5. Recently Approved Drugs: Olaparib for germline BRCA-mutated metastatic breast cancer

   Publicat: 30.05.2018
6. ASCO Guidelines: Outpatient Management of Fever and Neutropenia

   Publicat: 23.05.2018
7. Self-Evaluation: NSCLC Treatment Metastatic

   Publicat: 16.05.2018
8. Adjuvant Treatment in Melanoma: Recent Advances

   Publicat: 09.05.2018
9. Recently Approved Drugs: Blinatumomab for B-cell precursor ALL

   Publicat: 02.05.2018
10. Guidelines: Management of Immune-Related Adverse Events

    Publicat: 25.04.2018
11. Treatment Effects & Transition to Survivorship for AYA Patients

    Publicat: 18.04.2018
12. EHR Chemotherapy Error: Breast Cancer

    Publicat: 11.04.2018
13. Continuity of Care for AYAs

    Publicat: 04.04.2018
14. Self-Evaluation: Clinical Trials Informed Consent Process

    Publicat: 28.03.2018
15. Self-Evaluation: Clinical Trials

    Publicat: 14.03.2018
16. Self-Evaluation: NSCLC

    Publicat: 14.02.2018
17. Self-Evaluation: Breast Cancer

    Publicat: 07.02.2018
18. Self-Evaluation: Metastatic Breast Cancer

    Publicat: 13.12.2017
19. ASCO Guidelines: Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer Update

    Publicat: 06.12.2017
20. Recently Approved Drugs: Nivolumab for Metastatic Colorectal Cancer

    Publicat: 22.11.2017